Untuk Kegunaan UKM sahaja
For UKM use only
| Clinical Oncology , Sarjana Perubatan , UM , 2022 |
| PERUBATAN & SURGERI , Doktor (Perubatan) , UNIVERSITY OF MELBOURNE , 2010 |
| Nur Faizah Ab Muin; Marniza Saad; Adlinda Alip; Muthukkumaran Thiagarajan. (2023). The Outcomes Of Glioblastoma Multiforme:the University Malaya Medical Centre Experience 2008-2018. - Annals Of Oncology. S1411. |
| Izzati Yussof, Nur Faizah Ab Muin, Masnizah Mohd, Ernieda Hatah, Nor Asyikin Mohd Tahir, Noraida Mohamed Shah. (2023). Breast Cancer Prevention And Treatment Misinformation On Twitter: An Analysis Of Two Languages. - Digital Health. 1-11. |
| Nur Faizah Ab Muin, Marniza Saad, Adlinda Alip, Muthukkumaran Thiagarajan. (2024). The Outcomes Of Glioblastoma Multiforme: The University Malaya Medical Centre Experience 2008-2018. - Journal Of Health And Translational Medicine. 49-56. |
| Nur Faizah Ab Muin; Marniza Saad; Adlinda Alip; Muthukkumaran Thiagarajan. (2023). The Outcomes Of Glioblastoma Multiforme:the University Malaya Medical Centre Experience 2008-2018. - Annals Of Oncology. S1411. |
| Izzati Yussof, Nur Faizah Ab Muin, Masnizah Mohd, Ernieda Hatah, Nor Asyikin Mohd Tahir, Noraida Mohamed Shah. (2023). Breast Cancer Prevention And Treatment Misinformation On Twitter: An Analysis Of Two Languages. - Digital Health. 1-11. |
| Nor Aniza Azmi , Caryn Chan Mei Hsien , Nur Fa'izah Ab Muin , Ahmad Syahmiuddin Shamsuddin , Mohd Sukri Nur Afiqah , Ab Razak Mimi Syaqirah. (2023). Development Of A Psychosocial And Supportive Cancer Care Module For Therapy Radiographers In Malaysia: A Systematic Approach. - Journal Of Medical Imaging And Radiation Sciences. S15. |
| Noraida Mohamed Shah, Izzati Yussof, Nur Faizah Ab Muin, Norlia Abdullah, Ernieda Hatah, Nor Asyikin Mohd Tahir. (2023). Development And Validation Of A Patient Information Booklet On Endocrine Therapy For Breast Cancer Patients. - Malaysian Journal Of Medicine And Health Sciences. 13. |
| Zul Iskandar Johari, Nor Aniza Azmi, Nur Fa Izah Ab Muin, Rukiah A Latiff, Muhammad Safwan Ahmad Fadzil, Rosmizan Ahmad Razali. (2023). Two-dimensional And Three-dimensional Image-guided Evaluation Of Patient Positioning For Intensity-modulated Radiation Therapy Of Head And Neck Cancer. - Malaysian Journal Of Fundamental And Applied Sciences. 915-926. |
| Azmi Nor Aniza, Johari Zul Iskandar, Ab Muin Nur Fa'izah, A Latiff Rukiah, Ahmad Fadzil Muhammad Safwan, Ahmad Razali Rosmizan. (2023). Assessment Of Standardized Patient Positioning Protocols For Image-guidedimrt Of Head And Neck Cancer: A Single-centre Study. - Journal Of Medical Imaging And Radiation Sciences. S15-S16. |
| Nor Aniza Azmi , Caryn Chan Mei Hsien , Nur Fa'izah Ab Muin , Mimi Syaqirah , Ahmad Syahmiuddin Shamsuddin , Afiqah Shukri. (2023). Development Of Psychosocial And Supportive Cancer Patient Care Module For Therapy Radiographer In Malaysia: Student Version. - Journal Of Medical Imaging And Radiationsciences. S15. |
| Nur Fa'izah Ab Muin, Ho Gwo Fuang. (2022). The Response To Anaplastic Lymphoma Kinase Inhibitor In Metastatic Anaplastic Thyroid Carcinoma. - Brunei International Medical Journal. 84-88. |
| Nur Faizah Ab Muin, Ho Gwo Fuang. (2019). The Response To Anaplastic Lymphoma Kinase (alk) Inhibitor In Metastatic Anaplastic Thyroid Carcinoma (atc). - Esmo Asia Congress 2019. 1. |
| A Randomized, Open-Label Phase 2/3 Study of BT8009 as Monotherapy or in Combination in Participants with Locally Advanced or Metastatic Urothelial Cancer (Duravelo-2) , Ketua Projek , 25-07-2024 sehingga 24-03-2031 , Antarabangsa |
| Exploring Nuclear Security Culture: A Questionnaire-Based Survey , Ketua Projek , 16-05-2024 sehingga 15-11-2025 , Universiti |
| An open-label, multi-center, single arm, rollover study of GME751 (proposed pembrolizumab biosimilar) in participants who are eligible for continued pembrolizumab treatment after participation in CGME751A12101 or CGME751A12301 studies , Penyelidik Bersama , 20-11-2024 sehingga 19-05-2028 , Antarabangsa |
| THE CORRELATION OF PD-L1 POSITIVITY WITH DNA MISMATCH REPAIR AND THEIR ASSOCIATIONS WITH TUMOUR-INFILTRATING LYMPHOCYTES IN TRIPLE NEGATIVE BREAST CANCER PATIENTS , Penyelidik Bersama , 01-11-2024 sehingga 31-10-2026 , Universiti |
| A Randomized, Open-label Phase 3 Study of Amivantamab and mFOLFOX6 or FOLFIRI Versus Cetuximab and FOLFOX6 or FOLFIRI as First-line Treatment in Participants With KRAS/NRAS and BRAF Wild-type Unresectable or Metastatic Left-sided Colorectal Cancer , Penyelidik Bersama , 26-09-2024 sehingga 25-11-2028 , Antarabangsa |
| A Phase III, Open-label, Sponsor-blind, Randomized Study of Dato-DXd With or Without Osimertinib Versus Platinum-based Doublet Chemotherapy for Participants with EGFR-mutated Locally Advanced or Metastatic Non-small Cell Lung Cancer whose Disease has... , Penyelidik Bersama , 26-09-2024 sehingga 25-03-2028 , Antarabangsa |
| Development of novel exosomal microRNA signature as prognostic biomarkers for breast cancer treatment. , Penyelidik Bersama , 12-09-2024 sehingga 11-09-2027 , Kebangsaan |
| Elucidating The Role of LRG1 in FOLFOX Chemosensitization and Metabolic Secretome Modification in Colorectal Cancer via Metabolomic and Metallomic Approaches , Penyelidik Bersama , 01-08-2024 sehingga 31-07-2027 , Kebangsaan |
| A Randomized, Double-blind Study to Compare the Pharmacokinetics Between ABP 234 and Keytruda® (Pembrolizumab) in Subjects with Early-stage Non-squamous Non-small Cell Lung Cancer as Adjuvant Treatment Following Resection and Platinum-based Chemotherapy , Penyelidik Bersama , 25-07-2024 sehingga 24-05-2028 , Antarabangsa |
| A Randomized, Double-Blind Study to Compare Efficacy, Pharmacokinetics, Safety, and Immunogenicity Between ABP 234 and Keytruda® (Pembrolizumab) in Subjects with Advanced or Metastatic Non-squamous Non-Small Cell Lung Cancer , Penyelidik Bersama , 03-07-2024 sehingga 02-07-2029 , Antarabangsa |
| Tumour budding in invasive laryngeal squamous cell carcinoma and its correlation with clinicopathological parameters and overall survival in Hospital Canselor Tuanku Muhriz (HCTM). , Penyelidik Bersama , 27-06-2024 sehingga 26-07-2026 , Universiti |
| A Phase 1b/2, Open-label, Randomized Study of Vudalimab in Combination With Chemotherapy or Pembrolizumab in Combination With Chemotherapy as First-line Treatment in Patients With Advanced Non-small Cell Lung Cancer , Penyelidik Bersama , 13-05-2024 sehingga 12-08-2027 , Antarabangsa |
| A Randomized, Double-Blind Study Evaluating the Efficacy, Safety, and Immunogenicity of ABP 206 Compared with OPDIVO® (Nivolumab) in Subjects with Treatment-Naïve Unresectable or Metastatic Melanoma , Penyelidik Bersama , 04-01-2024 sehingga 03-10-2025 , Antarabangsa |
| A randomized, double-blind, parallel-group study to compare efficacy, safety, and immunogenicity of GME751 (proposed pembrolizumab biosimilar) and EU-authorized Keytruda® in adult participants with untreated metastatic non-squamous non-small cell lung can , Penyelidik Bersama , 21-12-2023 sehingga 20-06-2027 , Antarabangsa |
| A Global, Phase 3, Randomized, Multicenter, Open-Label Study to Investigate the Efficacy and Safety of Furmonertinib Compared to Platinum-Based Chemotherapy as First-LineTreatment for Patients with Locally Advanced or Metastatic Non-Small Cell Lung Cance , Penyelidik Bersama , 27-07-2023 sehingga 26-05-2029 , Antarabangsa |
| A Randomized, Double-blind Study Evaluating Pharmacokinetic Similarity of ABP 206 Compared With OPDIVO® (Nivolumab) in Resected Stage III or Stage IV Melanoma Subjects in the Adjuvant Setting , Penyelidik Bersama , 22-06-2023 sehingga 21-08-2025 , Antarabangsa |
| Phase 1 Study Investigating The Safety, Tolerability, Pharmacokinetics, And Preliminary Antitumor Activity Of The Anti‑OX40 Agonist Monoclonal Antibody BGB-A445 In Combination With The Anti-PD-1 Monoclonal Antibody Tislelizumab In Patients With Advanced S , Penyelidik Bersama , 10-11-2022 sehingga 09-11-2025 , Antarabangsa |
| A Phase 3 Study to Evaluate Zimberelimab (AB122) Monotherapy Compared to Standard Chemotherapy or Zimberelimab Combined with AB154 in Front-Line, PD-L1-Positive Locally Advanced or Metastatic Non-Small Cell Lung Cancer , Penyelidik Bersama , 25-03-2021 sehingga 24-12-2025 , Antarabangsa |
| A Randomized, Double-Blind, Parallel Group, Equivalence, Multicenter Phase III Trial to Compare the Efficacy, Safety, Pharmacokinetics and Immunogenicity of HD204 to Avastin® In Patients with Metastatic or Recurrent Non-Squamous Non-Small Cell Lung. , Penyelidik Bersama , 08-08-2019 sehingga 30-03-2025 , Antarabangsa |
| STELLA – A Randomized, Multicenter, Multinational, Double-Blind Study to Assess the Efficacy and Safety of MB02 (Bevacizumab Biosimilar Drug) Versus Avastin® in Combination With Carboplatin and Paclitaxel for the Treatment of Subjects With Stage IIIB/IV N , Penyelidik Bersama , 08-02-2018 sehingga 07-03-2021 , Antarabangsa |
| Pembangunan Modul Penjagaan Psikososial dan Sokongan untuk Juru X-Ray Terapi di, AHMAD SYAHMIUDDIN BIN SHAMSUDDIN, Sarjana |
| Penilaian kedudukan pesakit untuk terapi sinaran termodulat-intensiti bagi kanser, ZUL ISKANDAR BIN JOHARI, Sarjana |
| IZYAN SYAHIIDAH BINTI MOHD SAHELL, Sarjana |
| PEMBANGUNAN BAHAN PENDIDIKAN UNTUK PESAKIT KANSER PAYUDARA YANG MENGGUNAKAN TERAPI ENDOKRIN ADJUVAN, IZZATI BINTI YUSSOF, Doktor Falsafah |
| Malaysian Oncological Society , 02-01-2022 sehingga 02-01-2023 , Kebangsaan |
| Faculty Invitation for the 33rd Annual Scientific Congress of Malaysian Oncological Society (ASCOMOS) , 04-11-2022 sehingga 06-11-2022 , Kebangsaan |
| Malaysia Prostate Cancer Consensus (MyPCC) 2022 , 27-08-2022 sehingga 27-08-2022 , Kebangsaan |
| UNDANGAN SEBAGAI PENCERAMAH UNTUK 6 th JOHOR ONCOLOGY MEETING 2022 , 24-09-2022 sehingga 24-09-2022 , Kebangsaan |
| HOW TO DEAL WITH FEVER IN CHEMOTHERAPY PATIENTS , 17-12-2022 sehingga 17-12-2022 , Kebangsaan |
| Nur Fa'izah Binti Ab Muin , 20-08-2023 sehingga 20-08-2023 , Kampung / Taman |
| Nur Fa'izah Binti Ab Muin , 24-07-2023 sehingga 24-07-2023 , Kebangsaan |
| Malaysian Oncological Society , 02-01-2023 sehingga 02-01-2024 , Kebangsaan |
| Nur Fa'izah Binti Ab Muin , 04-03-2023 sehingga 04-03-2023 , Kebangsaan |
| Nur Fa'izah Binti Ab Muin , 08-06-2023 sehingga 08-06-2023 , Daerah / Jajahan |
| Nur Fa'izah Binti Ab Muin , 16-05-2023 sehingga 16-05-2023 , Daerah / Jajahan |
| Nur Fa'izah Binti Ab Muin , 06-10-2023 sehingga 08-10-2023 , Kebangsaan |
| Nur Fa'izah Binti Ab Muin , 12-10-2023 sehingga 12-10-2023 , Antarabangsa |
| Nur Fa'izah Binti Ab Muin , 22-11-2023 sehingga 22-11-2023 , Kebangsaan |
| Exceptional Long term Survival of an Elderly Patient with Metastatic Small Cell Neuroendocrine Carcinoma of the Cervix A Case Report , 10-03-2023 sehingga 10-03-2023 , Kebangsaan |
| Artificial intelligence based radiotherapy contouring and planning to improve global access to cancer care , 31-10-2023 sehingga 31-10-2023 , Antarabangsa |
| Knowledge regarding human papillomavirus and cervical cancer prevention among medical students in Thailand , 28-08-2023 sehingga 28-08-2023 , Antarabangsa |
| Nur Fa'izah Binti Ab Muin , 01-12-2023 sehingga 31-05-2024 , Kebangsaan |
| Master of Clinical Oncology , 10-06-2024 sehingga 30-11-2024 , Kebangsaan |
| General Reviewer Acknowledgement , 02-01-2023 sehingga 31-12-2024 , Antarabangsa |
| Penyediaan Kertas Soalan Onkologi Klinikal Bagi Peperiksaan MEDEX , 02-01-2023 sehingga 31-12-2024 , Kebangsaan |
| PALLIATIVE MEDICINE TRAINIEE EDUCATION MEETING , 20-02-2024 sehingga 20-02-2024 , Kebangsaan |
| PROMISE 2024 Breast Cancer Talk , 08-06-2024 sehingga 08-06-2024 , Kebangsaan |
| Masterclass in Systemic Cancer Therapy , 21-07-2024 sehingga 21-07-2024 , Kebangsaan |
| ASCOMOS Abstract Reviewer , 11-10-2024 sehingga 13-10-2024 , Kebangsaan |
| 35th Annual Scientific Congress of Malaysian Oncological Society , 11-10-2024 sehingga 13-10-2024 , Kebangsaan |
| JAWATANKUASA KUMPULAN KERJA INDIKATOR BAGI PROGRAM JAMINAN KUALITI (QAP) DALAM PERKHIDMATAN RADIOTERAPI DI BAWAH AKTA PERLESENAN TENAGA ATOM 1984 , 22-08-2024 sehingga 31-12-2025 , Kebangsaan |
| Expert for the Pan-Asia Adapted ESMO Clinical Practice Guidelines on Pancreatic Cancer , 21-07-2024 sehingga 21-07-2024 , Antarabangsa |
| Kongsi Kerjaya 6.0 SMK Dabong, Kuala Krai , 22-09-2024 sehingga 22-12-2024 , Daerah / Jajahan |
| Seminar Multidisciplinary Approach in Treating Cancer Patient , 04-09-2024 sehingga 04-09-2024 , Daerah / Jajahan |
| CLINICO-PATHOLOGICAL CONFERENCE DEPARTMENT OF OTORHINOLARYNGOLOGY-HEAD & NECK SURGERY, FACULTY OF MEDICINE UNILATERAL NASAL BLOCKAGE: UNVEILING THE HIDDEN THREAT , 03-07-2024 sehingga 03-07-2024 , Pusat Pengajian / Jabatan / Pusat Penyelidikan / Unit |
| CLINICO-PATHOLOGICAL CONFERENCE DEPARTMENT OF OTORHINOLARYNGOLOGY-HEAD & NECK SURGERY, FACULTY OF MEDICINE UNILATERAL NASAL BLOCKAGE: UNVEILING THE HIDDEN THREAT , 03-07-2024 sehingga 03-07-2024 , Pusat Pengajian / Jabatan / Pusat Penyelidikan / Unit |
| JAWATANKUASA PROGRAM MINGGU KESEDARAN KANSER PAYUDARA (PINKTOBER) 2024 , 30-09-2024 sehingga 04-10-2024 , Pusat Pengajian / Jabatan / Pusat Penyelidikan / Unit |
| Jawatankuasa Aduan dan Maklumbalas Pelanggan , 01-07-2016 sehingga 15-09-2018 , Pusat Pengajian / Jabatan / Pusat Penyelidikan / Unit |
| Jawatankuasa Kerja Pemilihan Pelajar Program Doktor Perubatan FPUKM , 22-03-2023 sehingga 31-12-2025 , Fakulti / Institut / Pusat Perkhidmatan |
| KLINIK VIRTUAL , 21-09-2023 sehingga 20-09-2024 , Fakulti / Institut / Pusat Perkhidmatan |
| PEGAWAI PENGURUS ADUAN DAN PENGESAH JAWAPAN ADUAN BAGI MODUL CUSTOMER FEEDBACK , 02-01-2023 sehingga 29-12-2023 , Fakulti / Institut / Pusat Perkhidmatan |
| PENGGUBALAN POLISI END OF LIFE CARE PERINGKAT HOSPITAL CANSELOR TUANKU MUHRIZ , 03-07-2023 sehingga 02-07-2025 , Fakulti / Institut / Pusat Perkhidmatan |
| SEBUT HARGA MEMBEKAL DAN MENGHANTAR UBAT APREPITANT CAP 80MG (2 , 02-01-2023 sehingga 29-12-2023 , Fakulti / Institut / Pusat Perkhidmatan |
| SEBUT HARGA MEMBEKAL DAN MENGHANTAR UBAT GEFITINIB 250MG TAB , 02-01-2023 sehingga 29-12-2023 , Fakulti / Institut / Pusat Perkhidmatan |
| SEBUT HARGA MEMBEKAL DAN MENGHANTAR UBAT LENVATINIB MESILATE 4MG HARD CAPSULE , 02-01-2023 sehingga 29-12-2023 , Fakulti / Institut / Pusat Perkhidmatan |